Attention-deficit hyperactivity disorder (ADHD) is described as the most common neurobehavioral condition of childhood. We raise the concern that ADHD is not a disease per se but rather a group of symptoms representing a final common behavioral pathway for a gamut of emotional, psychological, and/or learning problems. Increasing numbers of children, especially boys, are diagnosed with ADHD and treated with stimulant medications according to a simplified approach. Methodical review of the literature, however, raised concerning issues. “Core” ADHD symptoms of inattentiveness, hyperactivity and impulsivity are not unique to ADHD. Rates of “comorbid” psychiatric and learning problems, including depression and anxiety, range from 12 to 60%, with significant symptom overlap with ADHD, difficulties in diagnosis, and evidence-based treatment methods that do not include stimulant medications. No neuropsychologic test result is pathognomic for ADHD, and structural and functional neuroimaging studies have not identified a unique etiology for ADHD. No genetic marker has been consistently identified, and heritability studies are confounded by familial environmental factors. The validity of the Conners' Rating Scale-Revised has been seriously questioned, and parent and teacher “ratings” of school children are frequently discrepant, suggesting that use of subjective informant data via scale or interview does not form an objective basis for diagnosis of ADHD. Empiric diagnostic trials of stimulant medication that produce a behavioral response have been shown not to distinguish between children with and without “ADHD.” In summary, the working dogma that ADHD is a disease or neurobehavioral condition does not at this time hold up to scrutiny of evidence. Thorough evaluation of symptomatic children should be individualized, and include assessment of educational, psychologic, psychiatric, and family needs. (J Child Neurol 2005;20:994—1002).
Get full access to this article
View all access options for this article.
References
1.
American Academy of Pediatrics: Clinical practice guideline: Diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics2000;105:1158—1170.
2.
American Academy of Pediatrics: Clinical practice guideline: Treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics2001;108:1033—1044.
3.
Brown RT, Amler RW, Freeman WS, et al: Treatment of attention-deficit/hyperactivity disorder: Overview of the evidence. Pediatrics2005;115:e749—e757.
4.
Practice parameter for the use of stimulant medication in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry2002;41(2 Suppl):26S—49S.
5.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC, American Psychiatric Association, 1994.
6.
Rushton RL: Use of practice guidelines in the primary care of children with attention-deficit/hyperactivity disorder. Pediatrics2004;114:e23—e28.
Furman RA: Attention deficit/hyperactivity disorder: An alternative viewpoint. J Int ChildAdolesc Psychiatry2002;2:125—144.
9.
Weinberg WA, Brumback WA: The myth of attention deficithyperactivity disorder: Symptoms resulting from multiple causes. J Child Neurol1992;7:431—435.
10.
Carey WB: Is ADHD a valid disorder? in Jensen PS, Cooper JR (eds): Attention Deficit Hyperactivity Disorder: State of the Science. Best Practices. Kingston, NJ, Civic Research Institute, 2002 , 3-1—3-19.
11.
El-Sayed E. , Larsson JO, Persson HE, et al: “Maturational lag” hypothesis of attention deficit hyperactivity disorder: An update. Acta Paediatr2003;92:776—784.
12.
Coles G.: The Learning Mystique. New York, Pantheon Books, 1987.
13.
McGuiness D.: “ Attention deficit disorder: The emperor's clothes, animal “pharm,” and other fiction,” in Fisher S, Greenburg RP (eds): The Limits of Biological Treatments for Psychological Distress. Hillsdale, NJ, Lawrence Erlbaum Associates, 1989, 151—187.
14.
Rydelius PA: Children of alcoholic parents: At risk to experience violence and to develop violent behavior, in Chiland D, Young JG (eds): Children and Violence. Northvale, NJ, Jason Aronson, 1994 , 72—90.
15.
El-Sayed E.: May a genetically determined slow maturational rate explain AD/HD and hyperkinetic disorders: A proposal of an alternate hypothesis and methodologic aspects, licentiate thesis. Stockholm, Karolinska Institute, 1999.
16.
Mattes JA: The role of frontal lobe dysfunction in childhood dyskinesis. Comp Psychiatry1980;21:358—369.
17.
Sandberg S. : Hyperkinetic or attention deficit disorder . Br J Psychiatry1996;169:10—17.
18.
Taylor E.: Developmental psychopathology of hyperactivity, in Sargeant J (ed): European Approaches to Hyperkinetic Disorder . Zurich, Trumphimporteur, 1995, 173—189.
19.
Satin MS, Winsberg BG, Monetti CH, et al: A central population screen for attention deficit disorder with hyperactivity. J Child Psychol Psychiatry1985;24:756—764.
20.
Goldstein HS : Cognitive development in low attentive, hyperactive and aggressive 6 through 11 year old children. J Am Acad Child Adolesc Psychiatry1987;26:214—218.
21.
Dulcan M.: Practice parameter for the use of stimulant medication in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry1997;36(10 Suppl):85S—121S.
22.
Mill J.: Quantitative trait locus analysis of candidate gene alleles associated with attention deficit hyperactivity disorder (ADHD) in five genes: DRD4, DAT1, DRD5, SNAP-25, and 5HT1B. Am J Med Genet B Neuropsychiatr Genet2005;133:68—73.
23.
Faraone SV, Doyle AE, Mick E., Biederman J.: Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry2001;158:1052—1057.
24.
Manor I., Tyano S., Eisenberg J., et al: The short DRD4 repeats confer risk to attention-deficit/hyperactivity disorder in a family-based design and impair performance on a continuous performance test (TOVA). Mol Psychiatry2002;7:790—794.
25.
Kent L., Doerry U., Hardy E., et al: Evidence that variation at the serotonin transporter gene influences susceptibility to attention-deficit/hyperactivity disorder (ADHD): Analysis and pooled analysis. Mol Psychiatry2002; 7:908-912.
26.
Steffenssson B., Lichenstein P., Larsson JO, et al: Genetic disposition for global maturity: An explanation for genetic effects on parental report of AD/HD. Int J Behav Dev1999;23:357—374.
27.
Roth RM, Saykin AJ: Executive dysfunction in attention-deficit/hyperactivity disorder: Cognitive and neuroimaging findings. Psychiatr Clin North Am2004;27:83—96.
28.
Levy F., Hay DA, McStephen M., et al: Attention deficit hyperactivity disorder. A category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry1997;36: 737—744.
29.
Faraone SV: Genetics of adult attention-deficit/hyperactivity disorder. Psychiatr Clin North Am2004;27:303—321.
30.
Chronis AM, Lahey BB, Pelham WE, et al: Psychopathology and substance abuse in parents of young children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry2003;42:1424—1432.
31.
Johnston C. , Mash EJ: Families of children with attention-deficit/hyperactivity disorder: Review and recommendations for future research. Clin Child FamPsychol Rev2001;4:183—207.
32.
Fisher M.: Parenting stress and the child with attention-deficit/hyperactivity disorder . J Clin Child Psychol1990;19:337—346.
33.
Connor DF, Edwards G., Fletcher KE, et al: Correlates of comorbid psychopathology in children with ADHD . J Am Acad Child Adolesc Psychiatry2003;42:193—200.
34.
Giedd JN, Blumenthal J., Molloy E., Castellanos FX: Brain imaging of attention deficit/hyperactivity disorder. Ann N Y Acad Sci2001;931:33—49.
35.
Mostofsky SH : Smaller prefrontal and premotor volumes in boys with attention-deficit/hyperactivity disorder. Biol Psychiatry2002;52:785—794.
36.
Castellanos FX: Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA2002;288:1740—1748.
37.
Max JE, Fox PT, Lancaster JL, et al: Putamen lesions and the development of attention-deficit/hyperactivity symptomatology. J Am Acad Child Adolesc Psychiatry2002;41:563—571.
38.
Kates WR, Frederikse M., Mostofsky SH, et al: MRI parcellation of the frontal lobe in boys with attention-deficit/hyperactivity disorder or Tourette's syndrome. Psychiatry Res Neuroimaging2002;116:63—81.
39.
Berquin PC, Giedd JN, Jacobsen LK, et al: Cerebellum in attention-deficit/hyperactivity disorder: A morphometric MRI study. Neurology1998;50:1087—1093.
40.
Willis WG, Weiler MD: Neural substrates of attention deficit/hyperactivity disorder: Electroencephalographic and magnetic resonance imaging evidence. Dev Neuropsychol2005;27:135—182.
41.
Semrud-Clikeman M., Steingard RJ, Filipek P., et al: Using MRI to examine brain—behavior relationships in males with attention-deficit disorder with hyperactivity . J Am Acad Child Adolesc Psychiatry2000;39:477—484.
42.
Casey BJ: Implication of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry1997;36:374—383.
43.
Lou HC, Henriksen L., Bruhn P., et al: Striatal dysfunction in attention deficit and hyperkinetic disorder . Arch Neurol1989;46:48—52.
44.
Kim BN, Lee JS, Shin MS, et al: Regional cerebral perfusion abnormalities in attention deficit/hyperactivity disorder: Statistical parametric mapping analysis. Eur Arch Psychiatry Clin Neurosci2002;252:219—225.
45.
Ornitz EM: Developmental aspects of neurophysiology, in: Lewis M (ed): Child and Adolescent Psychiatry, A Comprehensive Textbook. Baltimore, MD, Williams and Wilkins, 1996, 324—335.
46.
Huttenlocher PR: Morphometric studies of human cerebral cortex development. Neuropsychologia1990;6:551—660.
47.
Thatcher RW : Maturation of the human frontal lobes: Physiological evidence for staging. Dev Neuropsychol1991 ;7:397—419.
48.
Hudspeth WJ , Pribram KH: Psychophysiological indices of cerebral maturation . Int J Psychophysiol1992; 12: 19—29.
49.
Bunge SA, Dudukovic NM, Thomason ME, et al: Immature frontal lobe contributions to cognitive control in children: Evidence from fMRI. Neuron2002;33:301—311.
Snyder SM, Drozd JF, Xenakis SN: Validation of ADHD Rating Scales, letter to the editor, discussion. J Am Acad Child Adolesc Psychiatry2004;43:1190—1191.
54.
Gianarris WJ , Golden CJ, Greene L.: The Conners' Parent Rating Scales: A critical review of the literature. Clin Psychol Rev2001;21:1061—1093.
55.
Lahey BB, McBurnett K., Piacentini JC: Agreement of parent and teacher rating scales with comprehensive clinical assessment of attention deficit disorder with hyperactivity. J Psychopathol Behav Assess1987;9:429—439.
56.
Safer D.: Commentary. J Am Acad Child Adolesc Psychiatry2000;39:989—992.
57.
Mitsis EM, McKay KE, Schulz KP, et al: Parent-teacher concordance for DSM-IV attention-deficit/hyperactivity disorder in a clinic-referred sample. J Am Acad Child Adolesc Psychiatry2000;39:308—313.
58.
Mulhern S., Dworkin PH, Bernstein B.: Do parental concerns predict a diagnosis of attention-deficit hyperactivity disorder?J Dev Behav Pediatr1994;15:348—352.
59.
Shea KM, Rahmani CH, Morris PJ: Diagnosing children with attention deficit disorders through a health department-public school partnership. Am J Public Health1996 ;86:1168—1169.
60.
Ullmann RK, Sleator EK, Sprague RL: ADD children: Who is referred from the schools?Psychopharmacol Bull1984;20:308—312.
61.
Sax L., Kautz KJ: Who first suggests the diagnosis of attention-deficit/hyperactivity disorder? AnnFam Med2003; 1: 171-174.
62.
Sayal K., Taylor E., Beecham J.: Parental perception of problems and mental health service use for hyperactivity . J Am Acad Child Adolesc Psychiatry2003;42:1410—1414.
63.
Butler SF, Arredondo DE, McCloskey V.: Affective comorbidity in children and adolescents with attention deficit hyperactivity disorder. Ann Clin Psychiatry1995;7:51—55.
64.
Pliszka SR: Psychiatric comorbidities in children with attention deficit hyperactivity disorder: Implications for management. PaediatrDrugs2003;5:741—750.
65.
Wolraich ML , Hannah JN, Baumgaertel A., Brown J.: Comparison of diagnostic criteria for attention deficit/hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry1996;35:319—324.
66.
Dilsaver SC , Henderson-Fuller S., Akiskal HS: Occult mood disorders in 104 consecutively presenting children referred for the treatment of attention-deficit/hyperactivity disorder in a community mental health clinic. J Clin Psychiatry2003;64: 1170—1176.
67.
Pliszka SR: Patterns of psychiatric comorbidity with attention deficit/hyperactivity disorder. ChildAdolesc Psychiatr Clin N Am2000;9:525—540.
68.
MTA Cooperative Group: A 14 month randomized clinical trial of treatment strategies for attention deficit/hyperactivity disorder. Arch Gen Psychiatry2000;56:1088—1096.
69.
Wilens TE, Biederman J., Brown S., et al. Psychiatric comorbidity and functioning in clinically referred preschool children and school-age youth with ADHD. J Am Acad Child Adolesc Psychiatry2002;41:262—268.
70.
Dankaerts M., Taylor E.: The epidemiology of childhood hyperactivity, in Verhulst FC, Koot HM (eds): The Epidemiology of Child and Adolescent Psychopathology. Oxford, England , Oxford University Press, 1995, 178—209.
71.
Pelham WE, Gnagy EM, Greenslade KE, Milich R.: Teacher ratings of DSM-III-R symptoms for the disruptive behavior disorders . J Am Acad Child Adolesc Psychiatry1992;31:210—218.
72.
Semrud-Clikeman M., Biederman J., Sprich-Buckminster S., et al: Comorbidity between ADDH and learning disability: A review and report in a clinically referred sample. J Am Acad Child Adolesc Psychiatry1992;31:439—448.
73.
Spencer T., Biederman J., Wilens T.: Attention-deficit/hyperactivity disorder and comorbidity. Pediatr Clin North Am1999;46:915—927.
74.
Brown TE (ed): Attention-Deficit Disorders and Comorbidities in Children, Adolescents, and Adults. Washington, DC, American Psychiatric Press, 2000.
75.
Jensen PS, Shervette RE III, Xenakis SN, Richters J.: Anxiety and depressive disorders in attention deficit disorder with hyperactivity: New findings. Am J Psychiatry1993;150:1203—1209.
76.
Connor DF, Edwards G., Fletcher KE, et al: Correlates of comorbid psychopathology in children with ADHD . J Am Acad Child Adolesc Psychiatry2003;42:193-200.
77.
Waxmonsky J. : Assessment and treatment of attention deficit hyperactivity disorder in children with comorbid psychiatric illness. Curr Opin Pediatr2003;15:476—482.
78.
Barkely RA, McMurray MB, Edelbrock CS, et al: The response of aggressive and nonaggressive ADHD children to two doses of methylphenidate. J Am Acad Child Adolesc Psychiatry1989; 28:873—881.
79.
Klorman R., Brumaghim JT, Salzman LF, et al: Comparative effects of methylphenidate on attention-deficit hyperactivity disorder with and without aggressive/noncompliant features. Psychopharmacol Bull1989;25:109—113.
80.
McGee R., Williams S., Moffett T., et al: A comparison of 13-year-old boys with attention deficit and/or reading disorder of neuropsychological measures. J Abnorm Child Psychol1989;17:37—53.
81.
Richardson E., Kupietz SS, Winsberg BG, et al: Effects of methylphenidate dosage in hyperactive reading-disabled children: II. Reading achievement. J Am Acad Child Adolesc Psychiatry1988;27:78—87.
82.
Korkman M., Pesonen AE: A comparison of neuropsychological test profiles of children with attention deficit-hyperactivity disorder and/or learning disorder. J Learn Disabil1994;27:383—392.
83.
Rie HE, Rie ED, Stewart S., Ambuel JP: Effects of Ritalin on underachieving children: A replication. Am J Orthopsychiatry1976;46:313—322.
84.
Barkley RA, Cunningham CE: Do stimulant drugs improve the performance of hyperkinetic children?Clin Pediatr1978;17:85—92.
85.
Douglas VI, Barr RG, O'Neill ME, et al: Short term effects of methylphenidate on the cognitive, learning and academic performance of children with attention deficit disorder in the laboratory and the classroom. J Child Psychol Psychiatry1986;27:191—211.
86.
Coyle JT: Depression and bipolar support alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in children and adolescents. J Am Acad Child Adolesc Psychiatry2003;42:1494—1503.
87.
Ryan ND: Diagnosing pediatric depression. Biol Psychiatry2001;49:1050—1054.
88.
Furman E.: What is depression in childhood? ChildAnalysis1992;4:101—123.
89.
Lewinsohn PM , Rohde P., Seeley JR, et al: Natural course of adolescent major depressive disorder in a community sample: predictors of recurrence in young adults. Am J Psychiatry2000;157:1584—1591.
90.
NationalAdvisory Mental Health Council's Workgroup on Child and Adolescent Mental Health Intervention Development and Deployment. Blueprint for Change: Research on Child and Adolescent Mental Health (NIH Publication01-4985). Rockville, MD, National Institute of Mental Health , 2001.
91.
Kowatch RA, Fristad M., Birmaher B., et al: Treatment guidelines for children and adolescents with bipolar disorder. J Child Psychol Psychiatry2005;44:213—235.
92.
Ford T.: The British Child and Adolescent Mental Health Survey 1999: The prevalence of DSM-IV disorders. J Am Acad Child Adolesc Psychiatry2003;42:1203—1211.
93.
Tannock R.: Attention deficit disorders with anxiety disorders, in Brown TE (ed): Subtypes of Attention Deficit Disorders in Children, Adolescents and Adults. New York, American Psychiatric Press, 1994, 930—959.
94.
Johnson JG, Cohen P., Brook JS: Associations between bipolar disorder and other psychiatric disorders during adolescence and early adulthood: A community-based longitudinal investigation . Am J Psychiatry2000;157:1679—1681.
95.
Pine DS, Cohen E., Cohen P., Brook J.: Adolescent depressive symptoms as predictors of adult depression: Moodiness or mood disorder?Am J Psychiatry1999;156:133—135.
96.
Pine DS, Cohen P., Brook J.: Adolescent fears as predictors of depression. Biol Psychiatry2001;50:721—724.
97.
Taylor E., Schachar R., Thorley G., et al: Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behavior. Psychol Med1987;17:121—143.
98.
Tannock R., Ickowica A., Schachar R.: Effects of comorbid anxiety disorder on stimulant response in children with ADHD. Presented at the 38th annual meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco, October 16—20, 1991.
99.
DuPaul GJ, Barkley RA, McMurray MB: Responses of children with ADHD to methylphenidate: Interaction with internalizing symptoms. J Am Acad Child Adolesc Psychiatry1994;33:894—903.
100.
Buitelaar JK, Van der Gaag RJ, Swaab-Barnevald H.: Prediction of clinical response to methylphenidate in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry1995;34:1025—1032.
101.
Compton SN : Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: An evidence-based medicine review. J Am Acad Child Adolesc Psychiatry2004;43:930—591.
102.
Levine K.: Attention-deficit/hyperactivity disorder—A non-organic point of view . Presented at Psychiatry Grand Rounds, University Hospitals, Cleveland, OH, 1991.
103.
Murphy JM, Wehler CA, Pagano ME, et al: Relationship between hunger and psychosocial functioning in low-income American children. J Am Acad Child Adolesc Psychiatry1998;37:163—170.
104.
Rappaport JL, Buchsbaum MS, Weingartner H., et al: Dextroamphetamine. Cognitive and behavioral effects in normal prepubertal boys. Science1978;199:560—563.
105.
Rappaport JL, Buchsbaum MS, Weingartner H., et al: Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and men. Arch Gen Psychiatry1980;37:933—943.
106.
Bernstein GA, Carroll ME, Crosby RD, et al: Caffeine effects on learning, performance and anxiety in normal school-age children. J Am Acad Child Adolesc Psychiatry1994;33:407—415.
107.
Rie HE: Effects of methylphenidate on underachieving children. J Consult Clin Psychol1976;44:250—260.
108.
Jacobvitz D., Sroufe LA, Stewart M., Leffert N.: Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: A comprehensive review. J Am Acad Child Adolesc Psychiatry1990;29:677—688.
Kratochvil CJ , Greenhill LL, March JS, et al: The role of stimulants in the treatment of preschool children with attention deficit/hyperactivity disorder. CNSDrugs2004;18:957—966.
111.
Fraser K.: Too young for attention deficit disorder? Views from preschool. J Dev Behav Pediatr2002;23:S46—S50.
112.
Gorski PA: Too young for ADHD: Early childhood diagnosis, labeling and treatment. Presented at the 37th Annual Miami Children's Hospital Postgraduate Course, January 25—31, 2002.
113.
Zito JM, Safer DJ, dosReis S., et al: Trends in the prescribing of psychotropic medication to preschoolers . JAMA2000;283:1025—1030.
114.
Diller L.: Lessons from three year olds. J Dev Behav Pediatr2002;23(1 Suppl):S10—S12.
115.
Hanisch C. , Konrad K., Gunther T., Herpertz-Dahlmann B: Agedependent neuropsychological deficits and effects of methylphenidate in children with attention-deficit/hyperactivity disorder: A comparison of pre- and grade-school children. J Neural Transm2004;111:865—881.
116.
Greenspan SI, Pollack GH (eds): The Course of Life. Psychoanalytic Contributions Toward Understanding Personality Development. Vol. I. Infancy and Early Childhood . Adelphi, MD, National Institute of Mental Health, 1980.
117.
Pozzi ME: Ritalin for whom? J Child Psychother2000;26:25—43.
118.
Jacobvitz D., Sroufe LA: The early caregiver child relationship and attention deficit disorder with hyperactivity in kindergarten: A prospective study. Child Dev1987;58:1488—1495.
119.
Lipkin PH, Butz AM, Cozen MA: High-dose methylphenidate treatment of attention deficit hyperactivity disorder in a preschooler. J Child Adolesc Psychopharmacol2003;13:103—106.
120.
Fireston P. , Musten LM, Pisterman S., et al: Short-term side effects of stimulant medication are increased in preschool children with attention-deficit/hyperactivity disorder: A double-blind placebo-controlled study. J Child Adolesc Psychopharmacol1998;8:13—25.
121.
Schieffer M., Weiss G., Cohen N., et al: Hyperactivity in preschoolers and the effect of methylphenidate. Am J Orthopsychiatry1975;45:38—50.
